Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-04-26 Purchase | 2021-04-28 4:15 pm | Syndax Pharmaceuticals Inc | SNDX | Meyers Michael L. SVP, Chief Medical Officer | 500 | $15.46 | $7,730 | 15,666 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-12 Option Award | 2024-06-14 4:10 pm | N/A 2034-06-12 | Nuvalent Inc. | NUVL | Meyers Michael L. Director | 6,288 | $0 | 6,288 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:17 pm | N/A 2033-06-15 | Nuvalent Inc. | NUVL | Meyers Michael L. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-10-04 Option Award | 2022-10-06 4:30 pm | N/A 2032-10-04 | Nuvalent Inc. | NUVL | Meyers Michael L. Director | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2022-10-06 4:25 pm | N/A 2031-04-29 | Nuvalent Inc. | NUVL | Meyers Michael L. Director | 0 | $0 | 8,361 (Direct) | View |
| 2022-01-31 Other | 2022-02-03 5:31 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Meyers Michael L. SVP, Chief Medical Officer | 1,714 | $12.39 | 42,344 (Direct) | View |
| 2022-02-02 Option Award | 2022-02-03 5:31 pm | N/A 2032-02-02 | Syndax Pharmaceuticals Inc | SNDX | Meyers Michael L. SVP, Chief Medical Officer | 17,350 | $15.79 | 42,344 (Direct) | View |
| 2021-12-30 Exercise | 2022-01-03 4:03 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Meyers Michael L. SVP, Chief Medical Officer | 5,900 | $8.77 | 21,566 (Direct) | View |
| 2021-12-30 Exercise | 2022-01-03 4:03 pm | N/A 2027-02-06 | Syndax Pharmaceuticals Inc | SNDX | Meyers Michael L. SVP, Chief Medical Officer | 5,900 | $0 | 21,566 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 4:21 pm | N/A 2031-02-03 | Syndax Pharmaceuticals Inc | SNDX | Meyers Michael L. SVP, Chief Medical Officer | 80,000 | $0 | 99,602 (Direct) | View |
| 2021-01-31 Other | 2021-02-05 4:21 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Meyers Michael L. SVP, Chief Medical Officer | 1,771 | $12 | 99,602 (Direct) | View |
| 2020-07-31 Other | 2021-02-05 4:21 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Meyers Michael L. SVP, Chief Medical Officer | 2,665 | $7.97 | 99,602 (Direct) | View |
| 2020-07-06 Option Award | 2020-07-08 4:11 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Meyers Michael L. SVP, Chief Medical Officer | 3,500 | $0 | 10,730 (Direct) | View |
| 2020-02-12 Option Award | 2020-02-14 4:36 pm | N/A 2030-02-12 | Syndax Pharmaceuticals Inc | SNDX | Meyers Michael L. SVP, Chief Medical Officer | 50,825 | $0 | 50,825 (Direct) | View |